Cost-Effectiveness of Inclisiran vs. Statin Therapy Across Time Horizons

A 5.5 KB Excel file uploaded to figshare by Mochou Liu on May 28, 2026. It contains cost-effectiveness results comparing the cholesterol-lowering drug inclisiran against statin monotherapy. The dataset likely contains modeled economic outcomes across different timeframes.

Use Cases

• Compare the incremental cost-effectiveness of inclisiran versus statins based on the described economic results.
• Analyze how cost-effectiveness ratios change over different time horizons as suggested by the dataset title.
• Validate or benchmark health economic models for cholesterol management therapies using the provided results.

Strengths

• Dataset is small (5.5 KB), facilitating quick download and inspection.
• Shared under a permissive CC-BY-4.0 license, allowing for reuse and adaptation.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for statistical analysis.

Provenance

Source

figshare

Freshness

Last updated 2026-05-28 17:30:46; freshness should be verified.